MPG.eBooks - Search Results

241

Endovascular therapy for patients with ischemic stroke : a review of the clinical and cost-effectiveness and guidelines

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

242

Acupuncture for chronic non-cancer pain : a review of clinical effectiveness, cost effectiveness, and guidelines

by Sutton, Desirée, McCormack, Suzanne
Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

243

Intravitreal dexamethasone implants for non-infectious uveitis : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Yu, Changhua, MacDougall, Danielle
Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

244

CADTH Canadian Drug Expert Committee recommendation: Sodium zirconium cyclosilicate (Lokelma -- Astrazeneca Canada Inc.) : indication: hyperkalemia

Published 2020

CADTH

Subjects: “...Cost-Benefit Analysis...”

Read Now

245

Natriuretic peptide testing for monitoring of heart failure therapy : a review of clinical effectiveness, clinical utility, cost-effectiveness, and guidelines

by Banerjee, Srabani, McCormack, Suzanne
Published 2019

CADTH

Subjects: “...Cost-Benefit Analysis...”

Read Now

246

Pharmacoeconomic review report: Dupilumab (Dupixent) (Sanofi-Aventis Canada Inc.)

Published 2018

CADTH

Subjects: “...Cost-Benefit Analysis...”

Read Now

247

Pharmacoeconomic review report: Lanadelumab (Takhzyro) (Shire pharma Canada ULC) : indication : for the routine prevention of attacks of hereditary angioedema in adolescents and ad...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

248

Clinical review report: Inotersen (Tegsedi) (Akcea therapeutics, inc.) : indication: stage I or II polyneuropathy in adults with hereditary transthyretin-mediated amyloidosis (hATT...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

249

Hysteroscopic tubal sterilization

Published 2014

IHE, Institute of Health Economics

Subjects: “...Cost-Benefit Analysis...”

Read Now

250

Bariatric treatments for adult obesity

Published 2012

IHE, Institute of Health Economics

Subjects: “...Cost-Benefit Analysis...”

Read Now

251

Insulin pump therapy for type 1 diabetes

Published 2012

Institute of Health Economics (IHE)

Subjects: “...Cost-Benefit Analysis...”

Read Now

252

CADTH Canadian Drug Expert Committee recommendation: Latanoprostene bunod (Vyzulta -- Bausch Health, Canada Inc.) : indication : for the reduction of intraocular pressure (IOP) in...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

253

Insulin pumps for diabetes

Published 2013

Swedish Council on Health Technology Assessment (SBU)

Subjects: “...Cost-Benefit Analysis...”

Read Now

254

Guanfacine hydrochloride extended-release for attention deficit hyperactivity disorder : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Harricharan, Sharada, Adcock, Lorna
Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

255

Percutaneous vertebroplasty and balloon kyphoplasty in treating painful osteoporotic vertebral compression fractures

Published 2011

SBU

Subjects: “...Cost-Benefit Analysis...”

Read Now

256

Laser interstitial thermal therapy for epilepsy and/or brain tumours : a review of clinical effectiveness and cost-effectiveness

by Williams, D., Loshak, Hannah
Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

257

Vibrating mesh nebulizers for patients with respiratory conditions : clinical effectiveness, cost-effectiveness, and guidelines

by Edge, Rob, Butcher, Robyn
Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

258

Effect of oseltamivir (TamifluR) for the prevention and treatment of influenza during an influenza pandemic

by Mørland, Berit
Published 2005

Norwegian Knowledge Centre for the Health Services

Subjects: “...Cost-Benefit Analysis...”

Read Now

259

Preventative foot care for patients with diabetes : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Chao, Yi-Sheng, Spry, Carolyn
Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

260

The use of health state utility values in decision models

by Ara, R., Wailoo, Allan
Published 2011

National Institute for Health and Clinical Excellence (NICE)

Subjects: “...Cost-Benefit Analysis...”

Narrow Search